M Amin Khan Selected Research

Lipids

12/2011	Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
11/2011	Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.
10/2011	In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Amin Khan Research Topics

Disease

2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 12/2011 - 05/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2007 - 06/2006
1	Sleep Deprivation 10/2019
1	Memory Disorders (Memory Loss) 10/2019
1	Mental Disorders (Mental Disorder) 10/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Fibromyalgia (Fibrositis) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Pain (Aches) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 11/2011
1	Neoplasms (Cancer) 11/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2011
1	Pelizaeus-Merzbacher Disease 10/2011
1	Rheumatoid Arthritis 02/2008
1	Parkinson Disease (Parkinson's Disease) 05/2007
1	Multiple Sclerosis 05/2007
1	Ischemia 11/2006
1	Brain Injuries (Brain Injury) 11/2006
1	Reperfusion Injury 11/2006
1	Necrosis 11/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 10/2019 - 11/2006
3	NYX-2925IBA 10/2019 - 01/2018
3	LipidsIBA 12/2011 - 10/2011
3	PlasmalogensIBA 12/2011 - 10/2011
3	AldehydesIBA 02/2008 - 11/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 01/2018
2	Ether (Diethyl Ether)IBA 12/2011 - 10/2011
2	PPI-1011IBA 12/2011 - 10/2011
2	PolyaminesIBA 11/2011 - 05/2007
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Ionotropic Glutamate ReceptorsIBA 01/2018
1	GLYX-13 peptideIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	N-Methylaspartate (NMDA)IBA 01/2018
1	Docosahexaenoic AcidsIBA 12/2011
1	phosphatidal ethanolaminesIBA 12/2011
1	DiaminesIBA 11/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2011
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2011
1	Membrane Transport Proteins (Biological Pump)IBA 11/2011
1	glycerophosphoethanolamineIBA 10/2011
1	Sulfhydryl Compounds (Thiols)IBA 02/2008
1	CytokinesIBA 02/2008
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2007
1	Sequestering AgentsIBA 11/2006
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 11/2006
1	hydrazine (hydrazine dihydrochloride)IBA 11/2006
1	Phenelzine (Nardil)FDA Link 11/2006

Therapy/Procedure

1	Oral Administration 01/2018
1	Analgesia 01/2018
1	Chemoprevention 11/2011
1	Therapeutics 06/2006